share_log

Piper Sandler Maintains Overweight on Apyx Medical, Raises Price Target to $4.5

Benzinga ·  Aug 11, 2023 12:29

Piper Sandler analyst Matt O'Brien maintains Apyx Medical (NASDAQ:APYX) with a Overweight and raises the price target from $4 to $4.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment